The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 24, 2026

Filed:

Apr. 01, 2020
Applicants:

Zhejiang Hisun Pharmaceutical Co., Ltd., Zhejiang, CN;

Shanghai Aryl Pharmtech Co., Ltd., Shanghai, CN;

Inventors:

Yanghui Guo, Zhejiang, CN;

Weiwei Liao, Zhejiang, CN;

Lichen Meng, Zhejiang, CN;

Taishan Hu, Zhejiang, CN;

Lei Chen, Zhejiang, CN;

Guoping Jiang, Zhejiang, CN;

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07C 233/55 (2006.01); A61P 25/02 (2006.01); C07D 223/16 (2006.01); C07D 267/14 (2006.01); C07D 413/04 (2006.01); C07D 413/10 (2006.01); C07D 413/14 (2006.01);
U.S. Cl.
CPC ...
C07C 233/55 (2013.01); A61P 25/02 (2018.01); C07D 223/16 (2013.01); C07D 267/14 (2013.01); C07D 413/04 (2013.01); C07D 413/10 (2013.01); C07D 413/14 (2013.01);
Abstract

The present invention relates to aromatic ring or heteroaromatic ring derivatives, a preparation method therefor and applications thereof in medicine. Specifically, the present invention relates to aromatic ring or heteroaromatic ring derivatives represented by general formula (I), a preparation method therefor and pharmaceutically acceptable salts thereof, as well as a use thereof as therapeutic agents, especially uses as angiotensin II type 2 receptor (ATR) antagonists, wherein the definition of each substituent in the general formula (I) is the same as the definition thereof in the description.


Find Patent Forward Citations

Loading…